BearingPoint Study Unveils Three Steps for Enhanced Welfare Services
1.8.2023 09:55:00 EEST | Business Wire | Press release
Management and technology consultancy BearingPoint has released its latest study, “Digital delivery holds the key for enabling better welfare services,” which examines the digital maturity of social welfare services across ten countries in Europe, North America, and Asia-Pacific. The study assesses the state of various social welfare programs, focusing on core industry digital dimensions and social protection categories, and highlights how governments are leveraging digital transformation to meet evolving socio-economic needs and introducing innovative solutions. The study identifies three crucial steps for government ministries and agencies responsible for social welfare services to enhance well-being outcomes for citizens:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230801342246/en/
• Reorient social welfare services around citizen segments and specific needs
• Rethink how to deliver true change and transformation in the delivery of services
• Realize tangible social and economic benefits for both public servants and citizens
This study explores why these actions are necessary, outlining what government leaders must do now and the anticipated benefits and outcomes.
Andrew Montgomery, Global Leader Government and Public Sector at BearingPoint, states: “Social welfare services form a significant part of annual expenditure for all governments, both in terms of citizen payments and service delivery costs. Our research and client experience highlights how digital and innovative technologies can improve the alignment of services with citizen needs, enable quicker responses to changing socio-economic conditions and ensure effective allocation of social welfare budgets.”
The global social welfare digital services leaders
As social welfare is a vast domain with many evolving digital developments, a simple, single-dimension maturity model would not provide any meaningful insight. Therefore, the study’s approach was multi-dimensional, examining the global digital service maturity of social welfare benefits across four digital dimensions and six social welfare categories. Of the ten countries assessed for their achievements in digitalizing access to social welfare services, the research shows that countries like Singapore, France, and Canada are typically at a higher level of digital maturity than others and offer leading practice examples. Singapore was the most digitally mature globally.
Countries were assessed on a score from 1-5 across four of the OECD’s Digital Dimensions (Digital by Design, User Driven, Government as a Platform, and Proactiveness) and the EU/EEA’s MISSOC Social Protection Categories (Unemployment, Health, Incapacity, Old-Age & Survivors, Family, and Social Assistance).
Digital by Design was the strongest dimension, with all countries optimized for digital applications and achieving an average score of 3.9 out of 5 across all categories. Proactiveness was the lowest scoring dimension across all categories, with an average aggregate score of 3.1, with opportunities identified for websites to include proactive prompts or auto-enrolment functionality.
Digital maturity in Unemployment is the strongest scoring (81%) and Incapacity (64%) the lowest in the MISSOC Social Protection Categories (Unemployment, Health, Incapacity, Old-Age & Survivors, Family, and Social Assistance).
About the study
The study examines the global digital service maturity of social welfare benefits across ten countries (Canada, Denmark, Estonia, France, Germany, Ireland, New Zealand, Norway, Singapore, and the UK), four digital dimensions, and six social welfare categories. It was based on desk-based research and validated with local contacts.
Download the study to find out more: https://www.bearingpoint.com/en/insights-events/insights/digital-strategy-for-citizens-well-being/
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230801342246/en/
Contact information
Alexander Bock
Global Senior Manager Communications
Telephone: +49 89 540338029
E-Mail: alexander.bock@bearingpoint.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
